Supernus Pharm (SUPN) Misses Q4 EPS by 10c
Supernus Pharm (NASDAQ: SUPN) reported Q4 EPS of ($0.65), $0.10 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
